Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations

Clinical trial NCT01410214 · UNKNOWN

Trial details

NCT number: NCT01410214
Sponsor: Chinese Lung Cancer Surgical Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIA

Start date: 2011-05-01
Primary completion: 2015-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.